• MK-2206 dihydrochloride: Applied Strategies in Akt Pathway M

  2026-06-08

  MK-2206 dihydrochloride empowers researchers to dissect PI3K/Akt/mTOR signaling with precision, enabling advanced apoptosis and persistence assays across cancer and infectious disease models. This guide delivers actionable protocols, troubleshooting insights, and applied innovations from the latest host-pathogen research.

• Sulfo-NHS-Biotin: Precision Protein Labeling for Surface Ass

  2026-06-08

  Sulfo-NHS-Biotin stands out for its water solubility and exclusive cell surface specificity, empowering researchers to achieve high-fidelity, amine-selective biotinylation without organic solvents. This guide explores advanced workflows, protocol optimizations, and troubleshooting strategies that maximize the reagent’s potential in proteomics, immunoprecipitation, and interaction mapping.

• O-Propargyl-Puromycin: Bridging Mitochondrial Integrity and

  2026-06-07

  This thought-leadership article explores how O-propargyl-puromycin (OPP) empowers translational researchers to dissect the mechanistic interplay between mitochondrial integrity, protein synthesis, and adaptive immunity. By integrating new mechanistic insights from recent immunology research with practical workflow guidance and a forward-looking perspective, the article advances beyond standard product pages to provide actionable, evidence-based strategies for translational research.

• Cy5 NHS ester(Et): Practical Guide for Biomolecule Labeling

  2026-06-06

  Cy5 NHS ester(Et) enables water-soluble, covalent fluorescent labeling of proteins and other biomolecules by targeting primary amines. It is particularly useful for immunofluorescence, flow cytometry, and microscopy workflows that require high labeling efficiency and minimal background. Ethanol-based protocols and long-term storage of dye solutions are not recommended for this reagent.

• Allosteric PDK4 Inhibitors: A New Avenue for Metabolic Disea

  2026-06-05

  The referenced study identifies a novel class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, with compound 8c demonstrating potent activity in vitro and in vivo. These findings provide a robust scaffold for metabolic disease drug development and reveal new intervention points for conditions such as diabetes, allergy, and cancer.

• Targeting CLK2 to Overcome Platinum Resistance in Ovarian Ca

  2026-06-05

  The referenced study identifies Cdc2-like kinase 2 (CLK2) as a key driver of platinum resistance in ovarian cancer through its phosphorylation of BRCA1 and enhancement of DNA damage repair. These findings open new avenues for alternative splicing modulation and targeted therapy in resistant ovarian tumors.

• Angiotensin 1/2 (2-7) Peptide: Advanced Insights for RAS and

  2026-06-04

  Explore the distinct biochemical and translational research applications of Angiotensin 1/2 (2-7), a vasoconstrictor peptide critical for blood pressure regulation and emerging viral pathogenesis studies. Gain unique protocol guidance and comparative analysis not found in standard reviews.

• Baicalein: Applied Protocols for Cancer & Inflammation Resea

  2026-06-04

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) stands out as a precision tool for dissecting cancer cell proliferation and inflammation pathways via 12-LOX inhibition. This article delivers hands-on experimental workflows, troubleshooting insights, and critical contrasts with emerging neuroprotective strategies, helping researchers maximize reproducibility and translational value.

• Cannabidiol Mitigates Orofacial Inflammatory Pain and Emotio

  2026-06-03

  This study demonstrates that cannabidiol (CBD) robustly attenuates both the sensory and affective components of orofacial inflammatory pain in mice through coordinated modulation of endocannabinoid and serotonergic pathways. The findings support CBD's translational potential for comprehensive management of pain and its comorbid emotional disturbances.

• Rotavirus Infection Disrupts Nrf2-Dependent Redox Defense Pa

  2026-06-03

  This study reveals that progressive rotavirus infection leads to a marked downregulation of the Nrf2 transcription factor and its antioxidant gene targets in host cells. By dissecting the timeline and regulatory mechanisms of Nrf2 suppression, the findings clarify viral strategies to subvert cellular redox homeostasis and suggest new directions for therapeutic intervention.

• AO/PI Double Staining Kit: Precision in Cell Viability Assay

  2026-06-02

  The AO/PI Double Staining Kit from APExBIO enables rapid, reliable discrimination between live, apoptotic, and necrotic cells using dual fluorescent dyes. Explore advanced applications, stepwise protocols, and troubleshooting tips that help elevate data clarity in apoptosis and necrosis detection.

• CFTRinh-172: Mechanistic Insights for Advancing CFTR Researc

  2026-06-02

  Explore how CFTRinh-172, a potent CFTR inhibitor, enables mechanistically precise studies in cystic fibrosis research. This article offers new perspectives on CFTR chloride channel regulation and practical assay optimization, building on the latest scientific findings.

• Sodium Picosulfate in Experimental Gut–Liver–Brain Axis Rese

  2026-06-01

  Explore the advanced roles of Sodium Picosulfate in gut–liver–brain axis studies, including mechanistic insights and practical assay guidance. This article delivers a unique, science-driven perspective on chronic constipation management and neuroinflammation models.

• SEC-seq Reveals VEGF-A Secretion Heterogeneity in MSCs

  2026-06-01

  The referenced study introduces SEC-seq, a method enabling simultaneous single-cell measurement of VEGF-A secretion and transcriptomics in mesenchymal stromal cells. This approach uncovers unanticipated heterogeneity in VEGF-A secretion, revealing that high secreting subpopulations are not reliably predicted by VEGFA transcript levels, with practical implications for cell therapy development and functional profiling.

• Targeted FGFR2 Fusion Suppression and Asparagine Depletion i

  2026-05-31

  This study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically targets FGFR2 fusion genes in intrahepatic cholangiocarcinoma (ICC). By combining FGFR2 fusion suppression with asparagine depletion, the research demonstrates enhanced inhibition of tumor growth and provides a mechanistic rationale for dual-targeted therapies.

16455 records 5/1097 page Previous Next 12345 下5页 Last page